Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’

Saved in:
Bibliographic Details
Published inEye (London) Vol. 32; no. 2; pp. 477 - 479
Main Author Nestel, A R
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.02.2018
Nature Publishing Group
Subjects
692/699/3161/1626
692/700/3934
Age
Angiogenesis Inhibitors
Correspondence
Humans
Intravitreal Injections
Laboratory Medicine
Macular Degeneration
Medicine
Medicine & Public Health
Ophthalmology
Pharmaceutical Sciences/Technology
Ranibizumab
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Surgery
Surgical Oncology
Treatment Outcome
Wet Macular Degeneration
Online AccessGet full text

Cover

Author Nestel, A R
Author_xml – sequence: 1
  givenname: A R
  surname: Nestel
  fullname: Nestel, A R
  email: achimnestel@nhs.net
  organization: Department of Ophthalmology, North Devon District Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29026187$$D View this record in MEDLINE/PubMed
BookMark eNptkc1u1DAUhS1URKeFHWsUiQ0LPPg6djxhgYRG5Ueq1E0X7CzHuQmuEnuwk4HZ9QlYl9frk-DRlKogVpFzPn320TkhRz54JOQ5sCWwcvUGd7jkDNSSAzwiCxCqolJIcUQWrJaMcs6_HJOTlK4Yy6FiT8gxrxmvYKUW5Oc6jCP6qQj-bXF7fXPhke7QxCKiGej3EIe2CPNkw4ipcL7YmMllPOXcots63xed-4EtbUPaH0w3uAajxc1UdCEWHsPWJDsPWWl6pBEHM2FbjObwr8UePcZsDf72-tdT8rgzQ8Jnd99Tcvnh7HL9iZ5ffPy8fn9OrWBqokJwDqJWprEl1tg00NSKlR0Yibm6KSuUK6kUtlIhWNnUXFgjwNrSAprylLw7aDdzM2Jrc6NoBr2JbjRxp4Nx-u_Eu6-6D1stVwCKyyx4dSeI4duMadKjSxaHweTCc9JQS5AVr8oqoy__Qa_CHH1ul6m6BgVc7KnXB8rGkFLE7v4xwPR-Z5131vuddd454y8eFriH_wybAXoAUo58j_HBrf8T_ga-5LoK
Cites_doi 10.1016/j.ophtha.2012.04.015
10.1038/eye.2017.6
ContentType Journal Article
Copyright Macmillan Publishers Limited, part of Springer Nature. 2018
Copyright Nature Publishing Group Feb 2018
Copyright © 2018 Macmillan Publishers Limited, part of Springer Nature. 2018 Macmillan Publishers Limited, part of Springer Nature.
Copyright_xml – notice: Macmillan Publishers Limited, part of Springer Nature. 2018
– notice: Copyright Nature Publishing Group Feb 2018
– notice: Copyright © 2018 Macmillan Publishers Limited, part of Springer Nature. 2018 Macmillan Publishers Limited, part of Springer Nature.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
8AO
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1038/eye.2017.211
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Health Medical collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
Biological Science Collection
AUTh Library subscriptions: ProQuest Central
ProQuest Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (Proquest) (PQ_SDU_P3)
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Health & Medical Collection (Alumni Edition)
Medical Database
Biological Science Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Central Student
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest Natural Science Collection
ProQuest Pharma Collection
ProQuest Central China
ProQuest Central
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Biological Science Collection
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Correspondence
EISSN 1476-5454
EndPage 479
ExternalDocumentID 10_1038_eye_2017_211
29026187
Genre Letter
Comment
Commentary
Correspondence
GroupedDBID ---
-Q-
.GJ
0R~
29G
2WC
36B
39C
3O-
3V.
4.4
406
53G
5RE
6PF
70F
7X7
88E
8AO
8FI
8FJ
8R4
8R5
AACDK
AANZL
AASML
AATNV
AAWBL
AAWTL
AAZLF
ABAKF
ABAWZ
ABCQX
ABDBF
ABJNI
ABLJU
ABUWG
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACZOJ
ADBBV
ADHDB
AEFQL
AEJRE
AEMSY
AENEX
AEVLU
AEXYK
AFBBN
AFFNX
AFKRA
AFSHS
AGAYW
AGEZK
AGHAI
AGQEE
AHMBA
AHSBF
AIGIU
AILAN
AJRNO
ALFFA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMYLF
AOIJS
AXYYD
B0M
BAWUL
BBNVY
BENPR
BHPHI
BKKNO
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DNIVK
DPUIP
E3Z
EAD
EAP
EBC
EBD
EBLON
EBS
EBX
EE.
EIOEI
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
FYUFA
GX1
HCIFZ
HMCUK
HYE
HZ~
IWAJR
JSO
JZLTJ
KQ8
L7B
M1P
M7P
NAO
NQJWS
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
Q2X
RNS
RNT
RNTTT
RPM
SNX
SNYQT
SOHCF
SRMVM
SV3
SWTZT
TAOOD
TBHMF
TDRGL
TR2
TUS
UKHRP
W2D
ZGI
ZXP
~8M
AAYZH
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7TK
7XB
8FE
8FH
8FK
AZQEC
DWQXO
GNUQQ
K9.
LK8
PQEST
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c407t-44221497abc3e9ebb1b9703f1a5e454a36e58577ed57e1c5b924ca41cc3c1ea3
IEDL.DBID RPM
ISSN 0950-222X
IngestDate Tue Sep 17 21:20:14 EDT 2024
Fri Aug 16 21:19:48 EDT 2024
Thu Oct 10 20:40:18 EDT 2024
Thu Sep 26 19:50:24 EDT 2024
Wed Oct 16 00:51:53 EDT 2024
Fri Oct 11 20:50:15 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c407t-44221497abc3e9ebb1b9703f1a5e454a36e58577ed57e1c5b924ca41cc3c1ea3
Notes SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
OpenAccessLink https://www.nature.com/articles/eye2017211.pdf
PMID 29026187
PQID 1999171246
PQPubID 33647
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5811725
proquest_miscellaneous_1951562636
proquest_journals_1999171246
crossref_primary_10_1038_eye_2017_211
pubmed_primary_29026187
springer_journals_10_1038_eye_2017_211
PublicationCentury 2000
PublicationDate 2018-02-01
PublicationDateYYYYMMDD 2018-02-01
PublicationDate_xml – month: 02
  year: 2018
  text: 2018-02-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle The Scientific Journal of The Royal College of Ophthalmologists
PublicationTitle Eye (London)
PublicationTitleAbbrev Eye
PublicationTitleAlternate Eye (Lond)
PublicationYear 2018
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Almuhtaseb, Kanavati, Rufai, Lotery (CR1) 2017; 31
Chakravarthy, Harding, Rogers, Downes, Lotery, Wordsworth (CR2) 2012; 119
28186507 - Eye (Lond). 2017 Jun;31(6):878-883
29052610 - Eye (Lond). 2018 Feb;32(2):479-481
U Chakravarthy (BFeye2017211_CR2) 2012; 119
H Almuhtaseb (BFeye2017211_CR1) 2017; 31
References_xml – volume: 119
  start-page: 1399
  issue: 7
  year: 2012
  end-page: 1411
  ident: CR2
  article-title: Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.04.015
  contributor:
    fullname: Wordsworth
– volume: 31
  start-page: 878
  issue: 6
  year: 2017
  end-page: 883
  ident: CR1
  article-title: One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration
  publication-title: Eye
  doi: 10.1038/eye.2017.6
  contributor:
    fullname: Lotery
– volume: 31
  start-page: 878
  issue: 6
  year: 2017
  ident: BFeye2017211_CR1
  publication-title: Eye
  doi: 10.1038/eye.2017.6
  contributor:
    fullname: H Almuhtaseb
– volume: 119
  start-page: 1399
  issue: 7
  year: 2012
  ident: BFeye2017211_CR2
  publication-title: Ophthalmology
  doi: 10.1016/j.ophtha.2012.04.015
  contributor:
    fullname: U Chakravarthy
SSID ssj0014770
Score 2.2317803
SourceID pubmedcentral
proquest
crossref
pubmed
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 477
SubjectTerms 692/699/3161/1626
692/700/3934
Age
Angiogenesis Inhibitors
Correspondence
Humans
Intravitreal Injections
Laboratory Medicine
Macular Degeneration
Medicine
Medicine & Public Health
Ophthalmology
Pharmaceutical Sciences/Technology
Ranibizumab
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Surgery
Surgical Oncology
Treatment Outcome
Wet Macular Degeneration
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLfGJiFeEIyPFQbKJGBPYUuTNi0vaJs2TUgbCA3p3qo09cFJox3cncT-hf3Vs9Nc4di018ZK0zj1R2z_DPAmtY0y1pUSHWpJ-rqQdVE4mWOukCxYg8iFwien-fE382mUjeKF2zSmVS5kYhDUTef5jnyHy-WVJW2Uf7z4JblrFEdXYwuNe7CWKsNh2rX9w9MvX4c4grGhXRzZEbuSNOEopr7v6mIHLxklU9n3qVLLSumGpXkzYfK_qGlQRkeP4GG0IsVez_bHsILtOtw_iXHyJ3DFdR80i-jaD2L7c4vykk60IAPxXAaMVNHNZ_TdOBWTVkRs1SmNe5zwDYMYT_5gI5uObxKEG4ckFE6AEWTjihaHBFZB4kiGehhsxE_XP2vwewCzZp5vP4Wzo8Ozg2MZuy5IT87dTBqT0l6W1tVeY4l1reqSxMJYuQxNZpzOkVwMa7HJLCqf1eTBeWeU99ordPoZrLZdixsguIWZpklc7sfGG1trmyF5bAxAk5Nfk8Dbxa5XFz22RhVi4rqoiDsVc6ci7iSwuWBJFf-wafX3PCSwNQzTv8EBD0cbMWcastYYbodonvccHF6Ulux9FjYBu8TbgYBxt5dH2smPgL-dcXFumiXwbnEK_lnWLet_cff6X8IDoiz6VPBNWJ39nuMrsnRm9et4nK8BIgMASw
  priority: 102
  providerName: ProQuest
Title Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’
URI https://link.springer.com/article/10.1038/eye.2017.211
https://www.ncbi.nlm.nih.gov/pubmed/29026187
https://www.proquest.com/docview/1999171246
https://search.proquest.com/docview/1951562636
https://pubmed.ncbi.nlm.nih.gov/PMC5811725
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0Blapeqn43QFeu1PbmXRw7cba3FoFQpaWootLeIseZpZHYLOruSnDjF3Auf49fwoyTrKD01GtsOZZnHL_JvHkG-BDbUhnrhhIdaknndSaLLHMyxVQhIViDyIXCo8P04Kf5Nk7Ga5B0tTCBtO-Lql-fTvt19StwK8-mftDxxAZHo92EqyPjZLAO61brLkRvUwfGhhviCDrsSDr8xi3bfUdnA7xgYUxl-xT1sArwkAMQJtPdPZIe4MyHdMm_cqbhKNp_Bk9bDCm-NHN9DmtYv4DHozZL_hKuuOqDRhGz-rO4ufzzvUZ5QR4tCCCeyqCRKmbLBfkazkVVi1ZbdU7tHiv-wyAm1TmWspzxnwThJoGEwgQYQRhX1LgisAr6HMlQD4OlmLrmWYknQcyabX5zef0Kjvf3jncPZHvvgvQU3i2kMXFMgZN1hdc4xKJQxZA-DBPlEjSJcTpFCjKsxTKxqHxSUAznnVHea6_Q6dewUc9qfAuCLzHTNIhL_cR4YwttE6Q1ZwkaWvk4go_dyudnjbpGHrLiOsvJWDkbKydjRbDdmSVv99g8ZwEFZQmfpBG8XzXT7uCUh6OlWHIfwmssuEN93jRWXL2oM38E9p59Vx1Yeft-CzlkUOBuHTCCT50n3JnWP-a_-d-v2IInNEjW8MS3YWPxe4nvCAYtih45_9j24NHXvcOjH72wCW4Bp_cN-w
link.rule.ids 230,315,733,786,790,891,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,74100,74657
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9QwDLfGkIAXNP6NwoAgAXvKtjRp0-MFIbTp2Hbj5ZDurUpT3zgJ2sHdSewr8Klnp7nCMcRrk6Zp7MR2bP8M8Cq1tTLWDSQ61JLkdSGronAyx1whabAGkROFR2f58LM5nmSTeOE2j2GVqzMxHNR16_mOfJ_T5ZUlaZS_u_guuWoUe1djCY0bcNNobZjP7aQ3uGgSoVgcaREHkuTgJAa-H-hiHy8ZI1PZvVSpdZF0Tc-8Hi75l880iKKjLbgbdUjxviP6PdjA5j7cGkUv-QP4xVkfNIpom7di91OD8pL4WZB6-FUGhFTRLhf01zgXs0ZEZNU5tXuc8f2CmM5-Yi3rlu8RhJuGEBQOfxGk4YoG-_BVQYeRDNkwWItvrntW43mAsmaK7z6E8dHh-MNQxpoL0pNpt5DGpCkZTdZVXuMAq0pVAzoUpsplaDLjdI5kYFiLdWZR-awi-807o7zXXqHTj2CzaRt8DIILmGkaxOV-aryxlbYZkr3G8DM5WTUJvF6tennRIWuUwSOui5KoUzJ1SqJOAjsrkpRxf83L39yQwMu-mXYGuzscLcSS-5CuxmA71Ge7o2D_oXTAtmdhE7BrtO07MOr2eksz-xLQtzNOzU2zBN6suOCPaf1j_k_-P_8XcHs4Hp2Wpx_PTp7CHXqr6ILCd2Bz8WOJz0jnWVTPA2NfAf6iAdI
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BkCZeJr4JDDASsCfTOnbidC8IAdX42OBhSH2LHOfCKkEyaCuxf4G_eneOGyhDvNZOavkuvjvf734H8CS1tTLWTSQ61JLsdSGronAyx1whebAGkQuFD4_yg8_m3SybRfzTIsIq12diOKjrzvMd-YjL5ZUla5SPmgiL-PR6-uL0u-QOUpxpje00LsMVspJjbuNgZ0PwRQsKjePIoxhLsomzCIIf62KEZ8yXqezzVKlN83TB57wInfwrfxrM0vQa7ER_UrzsFeA6XML2Bmwfxoz5TfjFFSD0FtG1-2LvY4vyjHRbkKv4VQa2VNGtlrQDuBDzVkSW1QWNe5zzXYNo5j-xlnXHdwrCNQGOwlAYQd6uaHGAsgo6mGSojMFafHP9bzV-CbTWLP29W3A8fXP86kDG_gvSU5i3lMakKQVQ1lVe4wSrSlUTOiAa5TI0mXE6Rwo2rMU6s6h8VlEs551R3muv0OnbsNV2Ld4Fwc3MNL3E5b4x3thK2wwpdmMqmpwinASerne9PO1ZNsqQHddFSdIpWTolSSeB3bVIyvitLcrfmpHA42GYvhJOfTjaiBXPIb-NiXdozp1egsMfpROOQwubgN2Q7TCBGbg3R9r5SWDizrhMN80SeLbWgj-W9Y_13_v_-h_BNul0-eHt0fv7cJUeKnp8-C5sLX-s8AG5P8vqYdDrc9rPBf4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comment+on%3A+%E2%80%98One-year+real-world+outcomes+in+patients+receiving+fixed-dosing+aflibercept+for+neovascular+age-related+macular+degeneration%E2%80%99&rft.jtitle=Eye+%28London%29&rft.au=Nestel%2C+A+R&rft.date=2018-02-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=32&rft.issue=2&rft.spage=477&rft.epage=479&rft_id=info:doi/10.1038%2Feye.2017.211&rft.externalDocID=10_1038_eye_2017_211
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon